Wow we agree on one point !!!
I don’t think the $1.80 is relevant point for anyone to look at , it was the green rush , greed meets hype and for every loser there was a big winner who left the party and probably talking up crypto or mushrooms or something else. This group said 2 years ago we won’t grow or process, at the time I disagreed with that but given the over supply so far they seem to right. They said they wanted to develop differentiated products capable of being registered , they are doing that , they said they were going to try and get a faster route to revenue via animal BUT leverage animal work in human AND leverage the hard shell capsule in animal which they are early stages of doing. I am not trying to pump just want the facts to be out there and support a board and management I have faith in . My 30cents is now 10 cents and I agree it’s going to be a journey but one I think will reward patience if they stay on track.
- Forums
- ASX - By Stock
- AC8
- Ann: Quarterly Cashflow and Market Update September 2021
Ann: Quarterly Cashflow and Market Update September 2021, page-13
Featured News
Add AC8 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online